Ledger.Open graph →
SEC Form D · Amendment · filed October 15, 2013

VERAX BIOMEDICAL INC

Offering
$11.8M
Sold
$8.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MARLBOROUGH, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Giles Hanson · Philadelphia, PAExecTonya J. Joly · New York, NYExec · DirectorJonathan E. Bain · Grand Cayman, Cayman IslandsDirectorGary A. Lieberman · New York, NYDirectorGregory Lawrence · MARLBOROUGH, MAExecPeter Fitzpatrick · Rye Brook, NYDirectorDennis Glazer · Rye Brook, NYExec · DirectorSteve O'Neill · Rye Brook, NYExec · DirectorDavid Welty · Philadelphia, PAExec · DirectorKevin Beyer · Philadelphia, PAExec · DirectorJon Groetzinger · New York, NYExec · DirectorJohn Locke · New York, NYExec · DirectorDavid Frankel · New York, NYDirectorRussell D'Souza · New York, NYExec · DirectorAfsaneh M. Beschloss · Washington, Washington, D.C.DirectorKevin Malloy · Denver, COExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗